Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Oncotarget|December 2, 2015
Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutationsShaohua Peng, Banibrata Sen, Tuhina Mazumdar, et al.Molecular Carcinogenesis|February 14, 2024
Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1Guangzhao Zhu, Fangxia Guan, Shenglei Li, et al.Cancer Letters|May 29, 2018
Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutantsNene N Kalu, Tuhina Mazumdar, Shaohua Peng, et al.Foods (Basel, Switzerland)|March 28, 2026
Dynamic Evolution of Aroma Characteristics in Ripened Pu-Erh Tea During Industrial Fermentation: Insights from GC-MS and Flavor Wheel AnalysisYiqing Guan, Qiuyue Chen, Nianguo Bo, et al.Journal of Translational Medicine|August 29, 2013
Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancersShaohua Peng, Chad J Creighton, Yiqun Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
PDK1 Mediates <i>NOTCH1</i>-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR InhibitionVaishnavi Sambandam, Mitchell J Frederick, Li Shen, et al.Cancer Letters|January 28, 2017
Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitorsMing Zhang, Ratnakar Singh, Shaohua Peng, et al.Molecular Cancer Therapeutics|September 7, 2014
A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinomaTuhina Mazumdar, Lauren A Byers, Patrick Kwok Shing Ng, et al.American Journal of Cancer Research|April 9, 2020
mTOR inhibition overcomes primary and acquired resistance to Wee1 inhibition by augmenting replication stress in epithelial ovarian cancersFuxia Li, Ensong Guo, Jia Huang, et al.Oncotarget|November 22, 2017
Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell linesNene N Kalu, Tuhina Mazumdar, Shaohua Peng, et al.Pageof 4